Bioptimus and 10x Genomics Launch STELA, World’s Largest Spatial Biology Atlas

Bioptimus has officially launched STELA, the world's largest clinically linked spatial biology atlas, marking a significant milestone in biotechnological research. The ambitious project aims to profile 100,000 patient specimens, representing a 20-fold increase in the scale of existing spatial biology data available globally. 10x Genomics (TXG) serves as a core strategic partner, utilizing its Xenium platform to generate high-resolution, AI-ready multi-omics data. This initiative is specifically designed to scale M-Optimus, a foundational AI model for biology focused on oncology and immunology. The partnership underscores the growing role of AI-driven drug discovery and validates the Xenium platform as an industry standard for large-scale clinical applications. Market analysts view this collaboration as a bullish signal for 10x Genomics, potentially driving long-term demand for its spatial profiling technology.

Fontes:prnewswire.comstocktitan.netstreetinsider.cominvesting.com